24.04.2017 - After a major slowdown in 2016, new drug approvals by the US Food and Drug Administration rose sharply in the first quarter of 2017, according to a report by EP Vantage. Up to mid...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)